Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1945]
News [3588]
Articles [92]
Editorials [5]
Conferences [157]
elearning [19]
No increased skin cancer risk with topical immunosuppressant ointments
No increased skin cancer risk with topical immunosuppressant ointments
Breast cancer 'ecosystem' reveals possible new targets for treatment
Breast cancer 'ecosystem' reveals possible new targets for treatment
COMBAT study preliminary results show response of 32% in treatment of pancreatic tumours
COMBAT study preliminary results show response of 32% in treatment of pancreatic tumours
Immunotherapy-resistant cancers eliminated in mouse study
Immunotherapy-resistant cancers eliminated in mouse study
Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma
Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma
IASLC WCLC 2020: CheckMate-743 shows that dual immunotherapy, nivolumab plus ipilimumab improves overall survival for patients with previously untreated mesothelioma
IASLC WCLC 2020: CheckMate-743 shows that dual immunotherapy, nivolumab plus ipilimumab improves overall survival...
IASLC WCLC 2020: Addition of sintilimab to pemetrexed and platinum improved progression-free survival in NSCLC
IASLC WCLC 2020: Addition of sintilimab to pemetrexed and platinum improved progression-free survival in NSCLC
New multiple myeloma therapy shows promise in preclinical study
New multiple myeloma therapy shows promise in preclinical study
FDA grants accelerated approval to belantamab mafodotin-blmf for multiple myeloma
FDA grants accelerated approval to belantamab mafodotin-blmf for multiple myeloma
TLK protein inhibition activates the innate immune system
TLK protein inhibition activates the innate immune system

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation